Apolipoprotein A I (APOA1) Goat Polyclonal Antibody

CAT#: R1029P

Apolipoprotein A I (APOA1) goat polyclonal antibody, Purified


USD 1,380.00

3 Days*

Size
    • 1 mg

Product Images

Specifications

Product Data
Applications ELISA, IHC, IP, WB
Recommended Dilution Anti-Apolipoprotein antibodies have been used for Indirect trapping ELISA for quantitation of antigen in serum using a standard curve, for Immunoprecipitation and for Western blotting for highly sensitive qualitative analysis.
Recommended Dilutions:
ELISA: 1/10,000-1/20,000.
Western blot: 1/1,000-1/2,000.
Immunoprecipitation: 1/100.
Immunohistochemistry: 1/50-1/200.
Reactivities Human
Host Goat
Clonality Polyclonal
Immunogen Apolipoprotein Type A-I was isolated from Human plasma by density gradient centrifugation followed by HPLC purification.
Specificity Typically less than 1% cross reactivity against other types of Apolipoprotein was detected by ELISA against purified standards.
This antibody reacts with Human Apolipoprotein A-I and has negligible cross-reactivity with Type A-II, B, C-I, C-II, C-III, E and J Apolipoproteins.
Non-specific cross reaction of anti-Apolipoprotein antibodies with other Human serum proteins is negligible.
Formulation 0.125M Sodium Borate, 0.075M Sodium Chloride, 0.005M EDTA, pH 8.0
State: Purified
State: Liquid (sterile filtered) purified IgG fraction
Stabilizer: None
Preservative: 0.01% Sodium Azide
Concentration lot specific
Purification Immunoaffinity Chromatography using immobilized antigens followed by extensive cross-adsorption against other Apolipoproteins and human serum proteins to remove any unwanted specificities.
Storage Store vial at 2-8°C prior to opening.
This product is stable at 2-8°C as an undiluted liquid. For extended storage mix with an equal volume of glycerol, aliquot contents and freeze at -20°C or below.
Avoid cycles of freezing and thawing.
Dilute only prior to immediate use.
Stability Shelf life: one year from despatch.
Background Apolipoprotein A I promotes cholesterol efflux from tissues to the liver for excretion. Apolipoprotein A I is the major protein component of high density lipoprotein (HDL) in the plasma. Synthesized in the liver and small intestine, it consists of two identical chains of 77 amino acids; an 18 amino acid signal peptide is removed co-translationally and a 6 amino acid propeptide is cleaved post-translationally. Apolipoprotein A I is a cofactor for lecithin cholesterolacyltransferase (LCAT) which is responsible for the formation of most plasma cholesteryl esters. Defects in the Apolipoprotein A I gene are associated with HDL deficiency and Tangier disease. The therapeutic potential of apoA-I has been recently assessed in patients with acute coronary syndromes, using a recombinant form of a naturally occurring variant of apoA-I. The availability of recombinant normal apoA-I should facilitate further investigation into the potential usefulness of apoA-I in preventing atherosclerotic vascular diseases.
Synonyms APOA1, ApoA-I, Apo-AI, ApoAI
Reference Data

{0} Product Review(s)

0 Product Review(s) Submit review

Be the first one to submit a review

Product Citations

*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.